Leephick Pharmaceutical Group is formed by Leephick Pharmaceutical Group (Hong Kong), Leephick Pharmaceutical Group (Philippines), Fujian Leephick Pharmaceutical Industry Co., Ltd, Longyan Leephick Investment Co., Ltd., Jiangxi Leephick Pharmaceutical Industry Co., Ltd., Fujian Minglong Pharmaceutical Industry Co., Ltd., Minglong Pharma USA, Longyan Leephick Yew Development Co., Ltd, and Leephick Chain Business Management Co., Ltd.
Having a strong technical research and management group formed by doctors and masters, Leephick involves in the research, manufacture and promoting many kinds of medicines. Especially, Leephick devoted itself in meeting the market requirements, and developed some hi-tech medicine for preventing and curing AIDS and tumour. It also focuses on finding solutions for diseases like diabetes and cardiovascular disease.
With healthy commercial network spreading all over the country and the markets of Southeast Asia and Middle East, Leephick establishes about 200 offices in more than 20 provinces of the country, which are well running by its capable marketing team of more than 1,000 experienced sales. And Leephick also spends great efforts on international market expansion.
To achieve sustainable development, Leephick builds up its brand image, develops the enterprise culture and brings forth new ideas in technology and management, all of which compose the long-term management tactics of Leephick Pharmaceutical Group. Meanwhile, Leephick is trying its best to realize the maximum benefits of its distinguished clients.